The Centre has started the process of identifying around 30 crore priority beneficiaries who will be given vaccine in the initial phase. The Centre will procure the vaccine directly and make it available free-of-cost for the priority beneficiaries.
At a media briefing after talks with Blinken, External Affairs Minister S Jaishankar thanked the US for its 'truly exceptional' support to India during the second wave of the pandemic and for keeping the supply chain for raw material open for vaccine production in India.
The government is considering setting up air freight stations to enable direct movement of vaccines from pharmaceutical factories to the aircraft.
The company has set an affordable ceiling price of USD 3 (around Rs 225) per dose, it added.
Police have arrested a shopkeeper in Gujarat's Kutch district for not taking vaccine against COVID-19, against the backdrop of the state government setting July 31 as the deadline for people in such businesses to get their first jab.
Modi said India has taken an important step forward in protecting its youth population against the disease.
About 18-19 coronavirus vaccine candidates are in different clinical trial stages and may be available in the coming months, Health Minister Harsh Vardhan said on Monday.
The Russian health ministry registered the first vaccine against COVID-19, named Sputnik V, on August 11.
There are a number of vaccine candidates already in clinical trial and a few out of those candidates have completed phase 1/2 status, he said, adding that there are trials that will be going into phase three sometime at the end of July and then others will follow in the months of August, September and October.
Pune-based Serum Institute of India (SII) is sitting on 200 million doses of Covishield that were manufactured in December and are set to expire in September. The company is likely to destroy these vaccines if nothing works out, Sohini Das reports.
AstraZeneca Plc and the University of Oxford are facing questions about their Covid-19 vaccine and whether regulators would quickly authorise its emergency use after the pharma company acknowledged an error in the vaccine dosage received by some participants and other irregularities and omissions, according to the New York Times.
The government has allowed import and export of COVID-19 vaccines without any value limitation, in order to ensure speedy clearance and distribution. The Central Board of Indirect Taxes and Customs (CBIC) has amended the regulations to facilitate the import/export of COVID-19 vaccines through courier, at locations where the Express Cargo Clearance System (ECCS) is operational. "Imports and exports of vaccines in relation to COVID-19 has been allowed without any value limitation," said the amended Courier Imports and Exports (Electronic Declaration and Processing) Amendment Regulations, 2020.
As many as 721,469 appointments were made through the national booking service on Friday -- the day of the announcement -- at an average of more than eight every second. To cope with demand, the NHS said it is using stadiums and football grounds as giant vaccination centres.
With the administration of 23,46,176 vaccine doses in the last 24 hours, the cumulative COVID-19 vaccine doses administered has exceeded 90.79 crore as per provisional reports till 7 am.
Each state has its own weak areas that need attention. Some states have already identified the gaps and sought the Centre's help. Vinay Umarji, Ishita Ayan Dutt, Samreen Ahmad and Sohini Das report.
A total of 10,93,954 vaccine doses were given till 7 pm on Thursday, the forty-eighth day of the nationwide COVID-19 vaccination drive.
'Across India, only nine personnel have refused to take the vaccine. All of them were given show cause notice...one did not respond, so in view of the lack of response, his service is already terminated'
The nurse was on Saturday admitted to hospital as she complained of uneasiness and fainted shortly after taking the shot, during the nationwide vaccination programme.
India's first mRNA platform-based vaccine will remain stable at 2-8 degrees Celsius while Pfizer-BioNTech's vaccine needs minus 70 degrees Celsius and Moderna vaccine can remain stable for six months at minus 20 degrees Celsius, reports Sohini Das.
The durability of immunity post COVID-19 vaccination persists for nine months or more and a precautionary dose of vaccine which will be administered to healthcare and frontline workers and citizens above 60 years with comorbidities is to mitigate the severity of infection, hospitalisation and death, the government said on Thursday.
In a letter to states and union territories, Union Health Secretary Rajesh Bhushan has suggested setting up of a state steering committee chaired by the chief secretary, a state task force led by additional Chief Secretary or principal secretary (health), and a district task force to be headed by the district magistrate.
Delhi requires 80 lakh doses a month to vaccinate its youth. But it only received 16 lakh doses in May. The Centre has further decreased Delhi's quota in June to 8 lakh doses, Kejriwal said.
The Centre on April 19 had announced a ''liberalised'' policy, making all above 18 years of age eligible to get vaccinated from May 1. It has also allowed state governments and private hospitals to purchase vaccines from manufacturers.
Five vaccine candidates are in advanced stages of development in India, out of which four are in Phase II/III and one is in Phase-I/II trials.
Modi made the remarks at a meeting, held via video conferencing, with district magistrates of over 40 districts having low vaccination coverage.
India's ace shooter Manu Bhaker on Tuesday received her first dose of COVID-19 vaccine at a government hospital in Jhajjar, Haryana, three months before the Tokyo Olympics where she will enter as one of India's brightest medal hopes.
World leaders thanked India for its help and support in combating the coronavirus pandemic through "early and meaningful" shipments of COVID-19 vaccine doses, as they addressed the high-level UN General Assembly session this year.
The countrywide vaccination drive was rolled out on January 16 with the inoculation of healthcare workers, while the vaccination of the frontline workers started from February 2.
According to the findings of the phase 1/2 randomised clinical trial, published in The Lancet Infectious Diseases journal, the vaccine candidate could induce an antibody response in participants within 28 days of the first immunisation, by giving two doses 14 days apart.
First a scientist and then a businessman, founder chairman Krishna Ella quit his faculty position at the Medical University of South Carolina in Charleston, United States, in 1996 to return to India.
Over one crore COVID-19 vaccine doses have been administered in the country till now with the highest single-day vaccinations of more than 6 lakh jabs given on Thursday, the Union health ministry said on Friday.
In a letter to all states and Union territories, the ministry highlighted that under the emergency use authorisation, coronavirus vaccination is indicated only for 18 years and above. If required, COVID-19 vaccine and other vaccines should be separated by an interval of at least 14 days.
Frontline healthcare staff, people over the age of 80 and care home workers will be among the first to get the vaccine as part of Phase 1 of the programme from Tuesday, which was approved for rollout by the UK's independent regulator earlier this week.
Of the 1,48,266 beneficiaries who were administered the vaccine on Monday, 8,656 were from Bihar, 1,822 from Assam, 36,888 from Karnataka, 7,070 from Kerala, 6,665 from Madhya Pradesh, 7,628 from Tamil Nadu, 10,352 from Telangana, 11,588 from West Bengal and 3,111 were from Delhi.
The Serum Institute of India, Bharat Biotech and Pfizer have applied to the DCGI seeking emergency use authorisation for their COVID-19 vaccine candidates and are awaiting approval.
Pune's Serum Institute of India, the world's largest vaccine maker by volume, is placing its bets on the Oxford-AstraZeneca vaccine candidate AZD1222 with CEO Adar Poonawalla stating he would start manufacturing at personal risk.
The GST Council on Friday left taxes on COVID-19 vaccines and medical supplies unchanged after the BJP- and Opposition-ruled states sparred over whether tax cut benefits will reach the common man. Congress and other Opposition ruled states have been demanding a reduction in taxes but the central government felt the move may not result in tangible gains for people. "It is one thing to rush to say - do this, it will benefit the common man. But when the technical, fitment and law committees go into the details, you realise that that could have collateral impact on many others," Finance Minister Nirmala Sitharaman said. "I am not talking about the revenue generation aspect, but how many other items will get included in it as a result of which how you are going to implement it," she added.
An expert panel of the country's drugs regulatory authority had recommended against granting such approval to the firm at this stage just two days ago, officials said.
The results show they induced strong antibody and T-cell immune responses for up to 56 days after they were given. T-cells are crucial for maintaining protection against the virus for years.
The Gam-COVID-Vac, called Sputnik V, is a two-part vaccine that includes two adenovirus vectors -- recombinant human adenovirus type 26 (rAd26-S) and recombinant human adenovirus type 5 (rAd5-S).
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances